期刊文献+

Control the Silver Content in the Preparation Process of Platinum Group Anti-cancer Drugs

Control the Silver Content in the Preparation Process of Platinum Group Anti-cancer Drugs
下载PDF
导出
摘要 In order to control the silver content in the preparation process of platinum group anti-cancer drugs, we put two kinds of color reagent to color in the production process of the platinum anti-cancer drugs by UV spectra measurement to control drugs production of platinum anticancer, thus we could control the silver content in the drugs so that it meets the pharmacopoeia standards of US and In order to control the silver content in the preparation process of platinum group anti-cancer drugs, we put two kinds of color reagent to color in the production process of the platinum anti-cancer drugs by UV spectra measurement to control drugs production of platinum anticancer, thus we could control the silver content in the drugs so that it meets the pharmacopoeia standards of US and European
出处 《贵金属》 CAS CSCD 北大核心 2012年第A01期243-245,共3页 Precious Metals
关键词 SILVER PLATINUM anti-cancer drugs silver platinum anti-cancer drugs
  • 相关文献

参考文献4

  • 1Bourikas T J, Vougiouka M. Cisplatin and platinum drags at the molecular level[J]. Oncol Rep, 2003, 10(6):1663.
  • 2EU Pharmacopoeia 7.3.
  • 3Li Xuejie. Guangzhou Chemical[J]. 2010, 38(12).
  • 4He Jian. patent no. 200910094394.0[P]. 2009-10-09.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部